Braden Carl Ishler is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical innovations, particularly in the treatment of coagulopathy. With a total of 10 patents to his name, Ishler's work focuses on advancing therapeutic methods that enhance patient care.

Latest Patents

One of Ishler's latest patents is titled "Thrombosomes as an antiplatelet agent reversal agent." This invention outlines a method for treating coagulopathy by administering a composition that includes platelets or platelet derivatives along with an incubating agent. The method is designed for subjects who have been treated with an antiplatelet agent. Another significant patent is "Platelet derivative compositions, and pluralities of containers containing same." This patent provides methods and compositions for treating coagulopathy, particularly for subjects who have received anticoagulant agents. These innovative approaches highlight Ishler's commitment to improving medical treatments.

Career Highlights

Braden Carl Ishler has established himself as a key figure in the medical innovation sector. His work at Cellphire, Inc. has allowed him to focus on developing groundbreaking solutions for coagulopathy treatment. His extensive research and patent portfolio reflect his dedication to advancing healthcare technologies.

Collaborations

Ishler has collaborated with notable colleagues, including Keith Andrew Moskowitz and Amber Nicole Lee. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and development.

Conclusion

Braden Carl Ishler is a distinguished inventor whose work in coagulopathy treatment has the potential to transform patient care. His innovative patents and collaborations underscore his significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.